These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 33211647)

  • 1. [Fight against COVID-19: market overview and pipeline of ongoing trials].
    Pontremoli R; Richard G; Vuddamalay G; Groux N
    Med Sci (Paris); 2020 Dec; 36(12):1225-1232. PubMed ID: 33211647
    [No Abstract]   [Full Text] [Related]  

  • 2. [The COVID-19 pandemic].
    Bessis S
    Med Mal Infect; 2020 Sep; 50(8S):8S20-8S24. PubMed ID: 33357972
    [No Abstract]   [Full Text] [Related]  

  • 3. The coronavirus outbreak could make it quicker and easier to trial drugs.
    Ledford H
    Nature; 2020 Jun; 582(7811):172. PubMed ID: 32504019
    [No Abstract]   [Full Text] [Related]  

  • 4. If a coronavirus vaccine arrives, can the world make enough?
    Khamsi R
    Nature; 2020 Apr; 580(7805):578-580. PubMed ID: 32273621
    [No Abstract]   [Full Text] [Related]  

  • 5. Behind Cuba's successful pandemic response.
    Burki T
    Lancet Infect Dis; 2021 Apr; 21(4):465-466. PubMed ID: 33773131
    [No Abstract]   [Full Text] [Related]  

  • 6. Dozens of coronavirus drugs are in development - what happens next?
    Ledford H
    Nature; 2020 May; 581(7808):247-248. PubMed ID: 32409766
    [No Abstract]   [Full Text] [Related]  

  • 7. Research during the SARS-CoV-2 pandemic.
    Muñoz de Nova JL; Ortega-Gómez M; Abad-Santos F;
    Med Clin (Barc); 2021 Jan; 156(1):39-40. PubMed ID: 33268132
    [No Abstract]   [Full Text] [Related]  

  • 8. Why do SARS-COV vaccines not exist? The pharma scientific intelligence and business model must be revisited!
    Boudjelal M; Nehdi A; Islam I
    Expert Opin Drug Discov; 2020 Nov; 15(11):1233-1235. PubMed ID: 32543297
    [No Abstract]   [Full Text] [Related]  

  • 9. COVID-19 vaccines and treatments: When speed is necessary and not enough.
    Grasela TH; Price DA; Wagner JA
    Clin Transl Sci; 2021 Jul; 14(4):1201-1205. PubMed ID: 33834614
    [No Abstract]   [Full Text] [Related]  

  • 10. COVID-19 vaccines for all?
    Usher AD
    Lancet; 2020 Jun; 395(10240):1822-1823. PubMed ID: 32534638
    [No Abstract]   [Full Text] [Related]  

  • 11. Commercial influence and covid-19.
    Moynihan R; Macdonald H; Bero L; Godlee F
    BMJ; 2020 Jun; 369():m2456. PubMed ID: 32580930
    [No Abstract]   [Full Text] [Related]  

  • 12. Tracking a Vaccine and Developing Therapeutics for COVID-19.
    Gould KA
    Dimens Crit Care Nurs; 2020; 39(6):293-297. PubMed ID: 33009266
    [No Abstract]   [Full Text] [Related]  

  • 13. [The urgency of deep institutional reforms in global health in the face of Covid-19 pandemic].
    Kazatchkine M
    Med Sci (Paris); 2020 Oct; 36(10):831-832. PubMed ID: 32975512
    [No Abstract]   [Full Text] [Related]  

  • 14. An update on the global vaccine development for coronavirus.
    Rab S; Afjal ; Javaid M; Haleem A; Vaishya R
    Diabetes Metab Syndr; 2020; 14(6):2053-2055. PubMed ID: 33113472
    [No Abstract]   [Full Text] [Related]  

  • 15. Global governance for COVID-19 vaccines.
    The Lancet
    Lancet; 2020 Jun; 395(10241):1883. PubMed ID: 32563355
    [No Abstract]   [Full Text] [Related]  

  • 16. Full Throttle: COVID-19 Open Science to Build Planetary Public Goods.
    Von Schomberg R; Özdemir V
    OMICS; 2020 Sep; 24(9):509-511. PubMed ID: 32628565
    [No Abstract]   [Full Text] [Related]  

  • 17. US Food and Drug Administration Support for Oncology Drug Development During COVID-19.
    Kadakia KT; Pazdur R; Shah A
    JAMA Oncol; 2021 Jan; 7(1):27-28. PubMed ID: 33030504
    [No Abstract]   [Full Text] [Related]  

  • 18. European countries in the race to attract successful biopharma investment: Winners and laggers.
    March-Chordà I; Yagüe-Perales RM
    Drug Discov Today; 2021 Oct; 26(10):2209-2213. PubMed ID: 33839291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Building the scientific commons. Conflictualities and pluralism in the light of clinical trials Covid-19].
    Israel-Jost V; Coutellec L
    Med Sci (Paris); 2021 Jan; 37(1):89-96. PubMed ID: 33492224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Covid-19 and the race for a vaccine.
    Cueto M
    Hist Cienc Saude Manguinhos; 2020; 27(3):715-717. PubMed ID: 33111785
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.